These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 20718882)

  • 21. Are treatments for vasovagal syncope effective? A meta-analysis.
    Vyas A; Swaminathan PD; Zimmerman MB; Olshansky B
    Int J Cardiol; 2013 Sep; 167(5):1906-11. PubMed ID: 22626839
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sex Differences in Vasovagal Syncope: A Post Hoc Analysis of the Prevention of Syncope Trials (POST) I and II.
    Deveau AP; Sheldon R; Maxey C; Ritchie D; Doucette S; Parkash R
    Can J Cardiol; 2020 Jan; 36(1):79-83. PubMed ID: 31810744
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of psychological factors in response to treatment in neurocardiogenic (vasovagal) syncope.
    Gracie J; Newton JL; Norton M; Baker C; Freeston M
    Europace; 2006 Aug; 8(8):636-43. PubMed ID: 16864617
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Modern management of vasovagal syncope].
    Djiane P
    Arch Mal Coeur Vaiss; 2006 Jan; 99(1):49-52. PubMed ID: 16479889
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pharma-clinics. How I treat vasovagal syncope].
    Kulbertus H; Melon P
    Rev Med Liege; 1999 Jun; 54(6):510-3. PubMed ID: 10446518
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Putting it together: a new treatment algorithm for vasovagal syncope and related disorders.
    Bloomfield DM; Sheldon R; Grubb BP; Calkins H; Sutton R
    Am J Cardiol; 1999 Oct; 84(8A):33Q-39Q. PubMed ID: 10568559
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of paroxetine hydrochloride, a selective serotonin reuptake inhibitor, on refractory vasovagal syncope: a randomized, double-blind, placebo-controlled study.
    Di Girolamo E; Di Iorio C; Sabatini P; Leonzio L; Barbone C; Barsotti A
    J Am Coll Cardiol; 1999 Apr; 33(5):1227-30. PubMed ID: 10193720
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overview of the contribution of recent clinical trials to advancement of syncope management.
    Moya A; Rivas N; Perez-Rodon J
    Prog Cardiovasc Dis; 2013; 55(4):396-401. PubMed ID: 23472777
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dysautonomia and neurocardiogenic syncope.
    McLeod KA
    Curr Opin Cardiol; 2001 Mar; 16(2):92-6. PubMed ID: 11224639
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The management of vasovagal syncope.
    Kenny RA; McNicholas T
    QJM; 2016 Dec; 109(12):767-773. PubMed ID: 27340222
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of closed-loop stimulation vs. DDD pacing on haemodynamic variations and occurrence of syncope induced by head-up tilt test in older patients with refractory cardioinhibitory vasovagal syncope: the Tilt test-Induced REsponse in Closed-loop Stimulation multicentre, prospective, single blind, randomized study.
    Palmisano P; Dell'Era G; Russo V; Zaccaria M; Mangia R; Bortnik M; De Vecchi F; Giubertoni A; Patti F; Magnani A; Nigro G; Rago A; Occhetta E; Accogli M
    Europace; 2018 May; 20(5):859-866. PubMed ID: 28407148
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of closed loop stimulation pacing (CLS) in vasovagal syncope.
    Ruzieh M; Ammari Z; Dasa O; Karim S; Grubb B
    Pacing Clin Electrophysiol; 2017 Nov; 40(11):1302-1307. PubMed ID: 28895151
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is this form of syncope to blame?
    Porr WA
    RN; 2004 Jun; 67(6):32-5. PubMed ID: 15317281
    [No Abstract]   [Full Text] [Related]  

  • 34. Evaluation of syncope: focus on diagnosis and treatment of neurally mediated syncope.
    Lee AK; Krahn AD
    Expert Rev Cardiovasc Ther; 2016 Jun; 14(6):725-36. PubMed ID: 26954877
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Syncope: pathophysiology, diagnosis, and pharmacotherapy.
    Lazarus JC; Mauro VF
    Ann Pharmacother; 1996 Sep; 30(9):994-1005. PubMed ID: 8876862
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomized clinical trials of neurally mediated syncope.
    Brignole M
    J Cardiovasc Electrophysiol; 2003 Sep; 14(9 Suppl):S64-9. PubMed ID: 12950522
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DDDR pacing driven by contractility versus DDI pacing in vasovagal syncope: a multicenter, randomized study.
    Deharo JC; Brunetto AB; Bellocci F; Barbonaglia L; Occhetta E; Fasciolo L; Bocchiardo M; Rognoni G
    Pacing Clin Electrophysiol; 2003 Jan; 26(1P2):447-50. PubMed ID: 12687864
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of tilt training in patients with vasovagal syncope.
    Gajek J; Zyśko D; Mazurek W
    Kardiol Pol; 2006 Jun; 64(6):602-8; discussion 609-10. PubMed ID: 16810579
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pacing in vasovagal syncope: Physiology, pacemaker sensors, and recent clinical trials-Precise patient selection and measurable benefit.
    Sutton R; de Jong JSY; Stewart JM; Fedorowski A; de Lange FJ
    Heart Rhythm; 2020 May; 17(5 Pt A):821-828. PubMed ID: 32036025
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Long-term prognosis in patients with vasovagal syncope after pacemaker implantation].
    Bałczewska D; Kaczmarek K; Ptaszyński P; Wranicz JK; Cygankiewicz I
    Pol Merkur Lekarski; 2016 Nov; 41(245):243-247. PubMed ID: 27883352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.